![](/img/cover-not-exists.png)
Development of the anti-IL-10 mAb MK-1966 in combination with in situ vaccination of a TLR9 agonist SD-101 for cancer immunotherapy
Phan, U., Ueda, R., Mangadu, R., Sathe, M., Rimmer, E., Vives, F., Ayanoglu, G., Yu, Y., Wong, J., Sadekova, S., McClanahan, T., Bhagwat, B., Willingham, A., Raubertas, R., Kastelein, R.Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32870-2
Date:
December, 2016
File:
PDF, 58 KB
english, 2016